World's Best Scientists 2026 revealed!
Gunnar Juliusson

Gunnar Juliusson

D-Index & Metrics

Medicine

D-Index
81
Citations
23809
World Ranking
16662
National Ranking
311

Overview

Gunnar Juliusson is affiliated with Lund University in Sweden and has a focused research career primarily in the field of medicine, with particular expertise in hematology. Their work spans multiple subfields including genetics, molecular biology, public health, environmental and occupational health, and oncology.

The scientist's research topics cover various aspects of hematological malignancies and treatments. Main topics include:

  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation

Gunnar Juliusson has published extensively in leading hematology and oncology journals. Frequent publication venues include:

  • Blood
  • Haematologica
  • Leukemia & Lymphoma / Leukemia and Lymphoma
  • Leukemia
  • Blood Cancer Journal

Some notable recent papers authored or co-authored by Juliusson are:

  • "First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia," 2023, New England Journal of Medicine
  • "The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting," 2020, Blood Advances
  • "Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications," 2022, Haematologica
  • "Hairy cell leukemia and COVID-19 adaptation of treatment guidelines," 2021, Leukemia
  • "A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial," 2021, Blood

The scientist frequently collaborates with multiple researchers in the field. Frequent co-authors include:

  • Martin Höglund
  • Vladimir Lazarević
  • Sören Lehmann
  • Tamar Tadmor
  • Stefan Deneberg

Overall, Gunnar Juliusson's scholarly activity is concentrated on the understanding, diagnosis, and treatment of various leukemias and related hematologic disorders, contributing both clinical and molecular insights to the field of hematology.

Best Publications

  • Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

    Gunnar Juliusson;Petar Antunovic;Åsa Derolf;Sören Lehmann

  • Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.

    Gunnar Juliusson;David G. Oscier;Margaret Fitchett;Fiona M. Ross

  • Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

    Stephen Johnson;Alister G. Smith;Helmut Löffler

  • Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

    Wolfgang U. Knauf;Toshko Lissichkov;Ali Aldaoud;Anna Liberati

  • Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome

    Jeanette Lundin;Hans Hagberg;Roland Repp;Eva Cavallin-Ståhl

  • Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

    Andreas Agathangelidis;Nikos Darzentas;Anastasia Hadzidimitriou;Xavier Brochet

  • Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

    Anders Castor;Lars Nilsson;Ingbritt Astrand-Grundström;Miranda Buitenhuis

  • Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

    Mark Levis;Farhad Ravandi;Eunice S. Wang;Maria R. Baer

  • Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

    Sören Lehmann;Vladimir J.N. Bykov;Dina Ali;Ove Andrén

  • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

    Jan J. Cornelissen;Alois Gratwohl;Richard F. Schlenk;Jorge Sierra

  • Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vλ2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

    Gerard Tobin;Ulf Thunberg;Anna Johnson;Inger Eriksson

  • FREQUENT GOOD PARTIAL REMISSIONS FROM THALIDOMIDE INCLUDING BEST RESPONSE EVER IN PATIENTS WITH ADVANCED REFRACTORY AND RELAPSED MYELOMA

    G Juliusson;F Celsing;I Turesson;S Lenhoff

  • Acute myeloid leukemia in the real world: why population-based registries are needed

    Gunnar Juliusson;Vladimir Lj Lazarevic;Ann-Sofi Hörstedt;Oskar Hagberg

  • Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

    P Baliakas;A Hadzidimitriou;L-A Sutton;D Rossi

  • Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

    S. Lehmann;A. Ravn;L. Carlsson;P. Antunovic

  • Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.

    Gerard Tobin;Ulf Thunberg;Karin Karlsson;Fiona Murray

  • Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

    Anders Waage;Peter Gimsing;Peter Fayers;Peter Fayers;Niels Abildgaard

  • Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

    Charles Crawley;Marc Lalancette;Richard Szydlo;Maria H Gilleece

  • Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma.

    A Osterborg;MA Boogaerts;R Cimino;U Essers

  • Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk

    Dalemari Crowther-Swanepoel;Peter Broderick;Maria Chiara Di Bernardo;Sara E. Dobbins

Frequent Co-Authors

Richard Rosenquist
Richard Rosenquist Karolinska Institute
Karin E. Smedby
Karin E. Smedby Karolinska University Hospital
David Oscier
David Oscier Royal Bournemouth Hospital
Paolo Ghia
Paolo Ghia Vita-Salute San Raffaele University
Šárka Pospíšilová
Šárka Pospíšilová Masaryk University
Kostas Stamatopoulos
Kostas Stamatopoulos Centre for Research and Technology Hellas
Frederic Davi
Frederic Davi Assistance Publique – Hôpitaux de Paris
Nicholas Chiorazzi
Nicholas Chiorazzi Feinstein Institute for Medical Research
Anton W. Langerak
Anton W. Langerak Erasmus University Rotterdam
Thoas Fioretos
Thoas Fioretos Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Planning a career in medicine doesn’t always mean attending medical school. There are several respected online degree programs that open doors to diverse roles in healthcare. Many professionals choose to earn a Master’s in Healthcare Administration, and there are now affordable mha online programs that prepare students for leadership positions in various health organizations.

For registered nurses aiming to advance their education, the best online dnp programs offer a pathway to a terminal degree while accommodating work schedules. Pharmacists and those interested in pharmacy can also benefit from flexible learning, with online pharmacy school cost now much more accessible thanks to affordable and reputable schools.

Additionally, health information management is an expanding field as digital records become the norm. Those seeking accreditation can explore rhia certification programs online to obtain the necessary skills for data-driven healthcare roles. By exploring these accredited online degrees, students can pursue meaningful healthcare careers even if they choose not to attend traditional medical school.

Best Scientists Citing Gunnar Juliusson

Trending Scientists

Recently Published Articles